Showing results (1-10 of 540) with videos related to
Sort By:
Pageof 54
Drugs of Today (Barcelona, Spain : 1998)|June 10, 2008
Fixed-dose lercanidipine/enalapril for hypertensionJan Menne, Hermann HallerJournal of Hypertension|July 10, 2010
Awareness and behaviour of European physicians in relation to microalbuminuria and organ damage: an ESH-endorsed surveyHermann Haller, Jan Menne, Giuseppe ManciaMedizinische Klinik (Munich, Germany : 1983)|August 25, 2009
[Hypertension 2007-2008]Christos Chatzikyrkou, Jan Menne, Hermann HallerJournal of Hypertension|July 17, 2010
Microalbuminuria as a risk factor: the influence of renin-angiotensin system blockadeJan Menne, Christos Chatzikyrkou, Hermann HallerJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 4, 2009
How to achieve renal protection in the light of ONTARGET?Christos Chatzikyrkou, Jan Menne, Hermann HallerExpert Opinion on Pharmacotherapy|June 17, 2009
The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalaprilChristos Chatzikyrkou, Hermann Haller, Jan MenneCurrent Opinion in Nephrology and Hypertension|December 3, 2015
Monocyte chemoattractant protein-1 and the kidneyHermann Haller, Anna Bertram, Felix Nadrowitz, et al.Current Hypertension Reports|April 27, 2016
Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?Hermann Haller, Anna Bertram, Klaus Stahl, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 11, 2012
Resistant hypertension: baroreflex stimulation as a new toolJan Menne, Jens Jordan, Silvia Linnenweber-Held, et al.Pageof 54